Key Takeaways
- • $17 billion acquisition announced: Bain Capital and Hellman & Friedman have agreed to jointly acquire Athenahealth from current owners Veritas Capital and Evergreen Coast Capital, with close expected in Q1 2022.
- • Second ownership change in three years: This marks the second significant ownership transition for the cloud-based EHR vendor in less than 36 months, following Veritas Capital's previous acquisition of the company.
- • Substantial provider network: Athenahealth operates a 140,000+ provider network across all 50 states and 120+ medical specialties in ambulatory care, positioning the platform as a critical healthcare infrastructure asset.
- • Vertical software expertise driving strategy: Both acquirers cited deep healthcare and software experience as rationale, with plans to accelerate product development, expand market share, and scale the business within a "highly scalable and vitally important end market."
- • Strategic exit for Veritas Capital: The sale follows September reporting that Veritas Capital and Elliott Investment Management were exploring strategic alternatives including an IPO or sale, culminating in this all-cash private equity transaction.
Summary
Bain Capital and Hellman & Friedman announced on November 22, 2021, a definitive agreement to acquire Athenahealth for $17 billion, in an all-cash transaction expected to close in the first quarter of 2022. The acquisition represents a significant reshuffling of ownership for the cloud-based electronic medical record vendor, which will transition from its current owners Veritas Capital and Evergreen Coast Capital to the two large-cap private equity firms.
The transaction marks Athenahealth's second major ownership change in less than three years. Veritas Capital had previously acquired the company, and Bloomberg reported in September 2021 that Veritas and Elliott Investment Management had initiated a strategic review exploring potential paths forward, including a sale or initial public offering. The $17 billion valuation reflects strong institutional demand for healthcare technology infrastructure assets, particularly cloud-based platforms servicing the ambulatory care market.
Athenahealth operates as a critical node in the healthcare IT ecosystem, partnering with more than 140,000 ambulatory care providers across all 50 states and spanning over 120 medical specialties. This expansive network positions the platform as essential infrastructure for independent practices, primary care facilities, and specialty providers nationwide.
Both acquirers emphasized their sector expertise in justifying the acquisition. Allen Thorpe, partner at Hellman & Friedman, stated the firm would work with management "to rapidly scale the business and continue to innovate" while building "a multi-sided digital care network between patient, payer, and provider." David Humphrey, managing director at Bain Capital Private Equity, highlighted plans to leverage "extensive vertical software and healthcare experience to help Athenahealth accelerate growth, develop new products, gain market share" in what he characterized as a "highly scalable and vitally important end market."
The deal structure positions Hellman & Friedman as the majority owner, with Bain Capital Private Equity and Bain Capital Tech Opportunities as co-investors, suggesting a multi-year value creation strategy combining operational scaling with technology innovation across the ambulatory care provider network.
The transaction marks Athenahealth's second major ownership change in less than three years. Veritas Capital had previously acquired the company, and Bloomberg reported in September 2021 that Veritas and Elliott Investment Management had initiated a strategic review exploring potential paths forward, including a sale or initial public offering. The $17 billion valuation reflects strong institutional demand for healthcare technology infrastructure assets, particularly cloud-based platforms servicing the ambulatory care market.
Athenahealth operates as a critical node in the healthcare IT ecosystem, partnering with more than 140,000 ambulatory care providers across all 50 states and spanning over 120 medical specialties. This expansive network positions the platform as essential infrastructure for independent practices, primary care facilities, and specialty providers nationwide.
Both acquirers emphasized their sector expertise in justifying the acquisition. Allen Thorpe, partner at Hellman & Friedman, stated the firm would work with management "to rapidly scale the business and continue to innovate" while building "a multi-sided digital care network between patient, payer, and provider." David Humphrey, managing director at Bain Capital Private Equity, highlighted plans to leverage "extensive vertical software and healthcare experience to help Athenahealth accelerate growth, develop new products, gain market share" in what he characterized as a "highly scalable and vitally important end market."
The deal structure positions Hellman & Friedman as the majority owner, with Bain Capital Private Equity and Bain Capital Tech Opportunities as co-investors, suggesting a multi-year value creation strategy combining operational scaling with technology innovation across the ambulatory care provider network.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.